CHOICES3: Sickle Cell Disease Parenting CHOICES
NCT05292781 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 506
Last updated 2026-01-15
Summary
The study will use web-based data collection (SCKnowIQ) and intervention delivery strategies enhanced by nudges and tailored boosters in a sample of 430 adult men and women, aged 18-45 yr with SCD (Sickle Cell Disease) or SCT (Sickle Cell Trait), at-risk, and planning within 2 years to have a child free of SCD.
Conditions
- Sickle Cell Disease
- Sickle Cell Trait
Interventions
- OTHER
-
CHOICES
An innovative web application to provide interactive information about reproductive health options for people with SCD or SCT. CHOICES is a multimedia intervention that provides targeted and tailored information for participants to become informed ns about their reproductive health options. Targeted to their sex and tailored to their SC reproductive health knowledge, reproductive health behavior during the previous 6 mo, and parenting plan (e.g., intention to have child with SCD or not), CHOICES presents information about options to help the participant achieve their parenting plan through reproductive partner selection based on sickle cell status, prenatal testing, ovum and sperm donation, advanced reproductive technologies, and options to avoid pregnancy or adopt. The website will be housed on secure University of Florida (UF) servers and accessible via computers or mobile devices (e.g., tablets, smart phones); device capture will inform plans for long-term dissemination.
- OTHER
-
eBook
e-Book contains information typically shared in clinical SCD care, including stick figure representation of inheritance because the investigator considers it unethical to withhold this basic information. It does not include other information related to the SCKnowIQ knowledge items or any of the behaviors needed to implement a parenting plan. Although not as long as CHOICES, the e-Book is sufficiently long, attractive, and engaging to retain participants randomized to the usual care control group; key factors for an adequate control condition. Interestingly, during the study and in interviews after the study, many e-Book participants commented that they were pleased to be assigned to the intervention group (they had not), which indicates that the control condition is sufficient for its intent--2-yr longitudinal retention of the sample. Also, human contact is the same for both groups, and the time-on-task on the computer is unlikely to influence study knowledge and behavior endpoints.
Sponsors & Collaborators
-
National Human Genome Research Institute (NHGRI)
collaborator NIH -
University of Florida
lead OTHER
Principal Investigators
-
Diana Wilkie, PhD · University of Florida
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-01
- Primary Completion
- 2027-06-30
- Completion
- 2027-06-30
Countries
- United States
Study Locations
More Related Trials
-
A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
NCT06290401 ·Status: RECRUITING ·Phase: NA
-
A Program to Increase Sickle Cell Trait Knowledge Among Parent of Young Children Identified in Newborn Screening
NCT03984500 ·Status: COMPLETED ·Phase: NA
-
Improving Self-Management in Adolescents With Sickle Cell Disease
NCT02851615 ·Status: COMPLETED ·Phase: NA
-
A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I
NCT03069430 ·Status: COMPLETED
-
SCRIPT: Sickle Cell Risk in Pregnancy Tool
NCT06529042 ·Status: ENROLLING_BY_INVITATION
-
Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)
NCT03380351 ·Status: COMPLETED
-
A Study to Learn About Sickle Cell Disease In Adult Patients
NCT05407805 ·Status: COMPLETED
-
Decision Aid for Therapeutic Options In Sickle Cell Disease
NCT02326597 ·Status: COMPLETED ·Phase: NA
-
Testing the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) Intervention
NCT06562439 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease
NCT01369160 ·Status: COMPLETED
-
Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program
NCT01569971 ·Status: COMPLETED
-
Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease
NCT02200510 ·Status: COMPLETED ·Phase: NA
-
SMYLS Multi-site Trial
NCT06035939 ·Status: RECRUITING ·Phase: NA
-
Predictors and Outcomes in Patients With Sickle Cell Disease
NCT03431935 ·Status: COMPLETED
-
Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings
NCT03619798 ·Status: UNKNOWN
-
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
NCT06941389 ·Status: RECRUITING
-
iCanCope With Sickle Cell Pain
NCT03201874 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
NCT03577691 ·Status: TERMINATED ·Phase: NA
-
iPeer2Peer Program for Youth With Sickle Cell Disease
NCT03989986 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Support Strategies for Parents During the First Year Following Their Child's Diagnosis of Sickle Cell Disorder
NCT06251843 ·Status: NOT_YET_RECRUITING
-
FOCUS for Pediatric Sickle Cell Disease and Cancer
NCT04075877 ·Status: UNKNOWN ·Phase: NA
-
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
NCT06919224 ·Status: RECRUITING ·Phase: NA
-
Sickle Cell Improvement: Enhancing Care in the Emergency Department
NCT05373771 ·Status: RECRUITING ·Phase: NA
-
Dose-Escalation Study of SCD-101 in Sickle Cell Disease
NCT02380079 ·Status: UNKNOWN ·Phase: PHASE1
-
Sickle Cell Anemia WE CARE
NCT03716726 ·Status: COMPLETED ·Phase: NA